Issue 4/2014

Insights into Enchondroma, Enchondromatosis and the risk of secondary Chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up (365 — 378)

G. W. HERGET, P. STROHM, C. ROTTENBURGER, U. KONTNY, T. KRAUß, J. BOHM, N. SUDKAMP, M. UHL

DOI: 10.4149/neo_2014_046

HOTAIR: a cancer-related long non-coding RNA (379 — 391)

B. CAI, X. Q. SONG, J. P.  CAI, S. ZHANG

DOI: 10.4149/neo_2014_075

In vitro and in vivo studies of antitumor effects of the recombinant immunotoxin MSH-PE38KDEL on melanoma (392 — 400)

Q. HUI, J. MA, J. SONG, Z. LIU, H. REN, W. JIANG, Y. WANG, Y. XU, D. GUO, X. ZHANG, S. LU

DOI: 10.4149/neo_2014_048

The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas (401 — 410)

X. Y. ZHU, L. WANG, S. H. LUAN, H. S. ZHANG, W. T. HUANG, N. H. WANG

DOI: 10.4149/neo_2014_049

Bad and Bid – potential background players in preneoplastic to neoplastic shift in human endometrium (411 — 415)

D. DRIAK, M. DVORSKA, P. BOLEHOVSKA, I. SVANDOVA, J. NOVOTNY, M. HALASKA

DOI: 10.4149/neo_2014_050

Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner (416 — 423)

X. L. JIANG, Y. ZHANG, B. TAN, C. L. LUO, X. H. WU

DOI: 10.4149/neo_2014_051

Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme (424 — 432)

B. WEI, L. WANG, X. ZHAO, Y. JIN, D. KONG, G. HU, Z. SUN

DOI: 10.4149/neo_2014_052

Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma (433 — 438)

H. KAYA, C. SEZGİ, A. C. TANRİKULU, M. TAYLAN, O. ABAKAY, H. S. SEN, A. ABAKAY, M. KUCUKONER, M. KAPAN

DOI: 10.4149/neo_2014_053

Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients (439 — 447)

V. PUZOVIC, I. BRCIC, I. RANOGAJEC, J. JAKIC-RAZUMOVIC

DOI: 10.4149/neo_2014_054

Up front hepatectomy for metastatic rectal carcinoma – reversed, liver first approach. Early experience with 15 patients. (447 — 452)

M. STRAKA, M. SKROVINA, R. SOUMAROVA, R. KOTASEK, L. BURDA, C. VOJTEK

DOI: 10.4149/neo_2014_055

Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma (453 — 460)

X. LI, H. YANG, Q. TIAN, Y. LIU, Y. WENG

DOI: 10.4149/neo_2014_056

PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer (461 — 467)

Y. ZHANG, M. LIU, H. YANG, J. WANG, H. LIU, X. LI, J. LI, J. XU, X. LI

DOI: 10.4149/neo_2014_057

Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients (468 — 475)

Y. Q. PAN, X. ZHANG, D. P. XU, W. G. BAO, A. F. LIN, H. H. XU, W. H. YAN

DOI: 10.4149/neo_2014_058

High TBX2 expression predicts poor prognosis in non-small cell lung cancer (476 — 481)

Z. ZHANG, Y. GUO

DOI: 10.4149/neo_2014_059

A meta-analysis of the association between CTLA-4 +49 A/G, −318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer (481 — 490)

Y. H. LEE, G. G. SONG

DOI: 10.4149/neo_2014_060